⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

April 29, 2019BMC GeriatricsOpen Access

Validation of Addenbrooke’s cognitive examination III for detecting mild cognitive impairment and dementia in Japan

Shintaro Takenoshita Seishi Terada Hidenori Yoshida Megumi Yamaguchi Mayumi Yabe Nao Imai Makiko Horiuchi Tomoko Miki Osamu Yokota Norihito Yamada

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to validate the Addenbrooke’s Cognitive Examination III (ACE-III) for detecting mild cognitive impairment (MCI) and dementia in a Japanese population.
Conducted validation study of ACE-III in Japanese clinical settings.
Evaluated its effectiveness in identifying MCI and dementia.
ACE-III effectively detects MCI and dementia in the studied population.
Demonstrated high accuracy in clinical practice for cognitive assessment.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Implication

Validation study shows ACE-III effectively detects mild cognitive impairment and dementia in Japan, suggesting its clinical applicability.

Abstract

ACE-III is a useful cognitive test to detect MCI and dementia. ACE-III may be widely useful in clinical practice.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Takenoshita et al. (2019) studied this question.

synapsesocial.com/papers/69e222d5caf46d2d8c86b6f3 https://doi.org/10.1186/s12877-019-1120-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological testsCross-Sectional Study · 2016 · 108 citations
2The Utility of Addenbrooke’s Cognitive Examination III (ACE-III) in Differentiating Neurodegenerative Disorders with Psychotic Symptoms: A Narrative ReviewLiterature Review · 2026 · 1 citations
3Validation of the Addenbrooke's Cognitive Examination III in Frontotemporal Dementia and Alzheimer's DiseaseOriginal Research · 2013 · 976 citations
4Improved Accuracy of the Addenbrooke’s Cognitive Examination–Revised in the Diagnosis of Mild Cognitive Impairment, Mild Dementia Due to Alzheimer’s Disease and Behavioral Variant Frontotemporal Dementia Using Mokken Scale Analysis2024 · 3 citations
5Validation of the German Revised Addenbrooke’s Cognitive Examination for Detecting Mild Cognitive Impairment, Mild Dementia in Alzheimer’s Disease and Frontotemporal Lobar DegenerationOriginal Research · 2010 · 64 citations
6Psychometric properties and diagnostic utility of the Mini-Addenbrooke’s Cognitive Examination (M-ACE) for detecting Major Neurocognitive Disorder in primary healthcare settingsOriginal Research · 2026 · 1 citations
7Is the ACE-III an effective cognitive screening tool for service users with acquired brain injuries? A descriptive service evaluation comparing cognitive results in CABISOriginal Research · 2026
8Toward a new standard for the Addenbrooke’s Cognitive Examination-III (ACE-III) adaptation – Lithuanian normative data for community-dwelling adultsOriginal Research · 2026
9Multimorbidity patterns and their associations with sociodemographic factors, lifestyle behaviors, and mental health status among older adults in the frigid zone of ChinaBMC Geriatrics · 2026
10Development and psychometric evaluation of the medical visit accompaniment service needs scale for older outpatients (MVASNS)BMC Geriatrics · 2026

More from BMC Geriatrics

More from Okayama University